Dr. Dean Regier
Senior Scientist, Cancer Control Research, BC Cancer
Dr. Regier is a Senior Scientist within Cancer Control Research, BC Cancer, and an Associate Professor at the School of Population and Public Health, Faculty of Medicine, University of British Columbia. Over the past 15 years, Dr. Regier’s research has focused on the economics of access to precision medicine, particularly in context to generating and using real world evidence to support sustainable regulatory and learning healthcare systems. He has presented his work internationally, with invitations from the US National Academies of Sciences and the World Economic Forum. He is Deputy Editor at the International Journal of Technology Assessment in Health Care and currently serves on BC’s Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about the listing of drugs on the PharmaCare program formulary.
Dr. Regier is a Senior Scientist within Cancer Control Research, BC Cancer, and an Associate Professor at the School of Population and Public Health, Faculty of Medicine, University of British Columbia. Over the past 15 years, Dr. Regier’s research has focused on the economics of access to precision medicine, particularly in context to generating and using real world evidence to support sustainable regulatory and learning healthcare systems. He has presented his work internationally, with invitations from the US National Academies of Sciences and the World Economic Forum. He is Deputy Editor at the International Journal of Technology Assessment in Health Care and currently serves on BC’s Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about the listing of drugs on the PharmaCare program formulary.
